Journal article

Restoration of Megalin-Mediated Clearance of Alveolar Protein as a Novel Therapeutic Approach for Acute Lung Injury


Authors listVohwinkel, Christine U.; Buchaeckert, Yasmin; Al-Tamari, Hamza M.; Mazzocchi, Luciana C.; Eltzschig, Holger K.; Mayer, Konstantin; Morty, Rory E.; Herold, Susanne; Seeger, Werner; Pullamsetti, Soni S.; Vadasz, Istvan

Publication year2017

Pages589-602

JournalAmerican Journal of Respiratory Cell and Molecular Biology

Volume number57

Issue number5

ISSN1044-1549

eISSN1535-4989

Open access statusGreen

DOI Linkhttps://doi.org/10.1165/rcmb.2016-0358OC

PublisherAmerican Thoracic Society


Abstract
Acute respiratory distress syndrome constitutes a significant disease burden with regard to both morbidity and mortality. Current therapies are mostly supportive and do not address the underlying pathophysiologic mechanisms. Removal of protein-rich alveolar edema-alpha clinical hallmark of acute respiratory distress syndromeis critical for survival. Here, we describe a transforming growth factor (TGF)-beta-triggered mechanism, in which megalin, the primary mediator of alveolar protein transport, is negatively regulated by glycogen synthase kinase (GSK) 3 beta, with protein phosphatase 1 and nuclear inhibitor of protein phosphatase 1 being involved in the signaling cascade. Inhibition of GSK3 beta rescued transepithelial protein clearance in primary alveolar epithelial cells after TGF-beta treatment. Moreover, in a bleomycin-based model of acute lung injury, megalin(+/-) animals (the megalin(-/-) variant is lethal due to postnatal respiratory failure) showed a marked increase in intraalveolar protein and more severe lung injury compared with wild-type littermates. In contrast, wild-type mice treated with the clinically relevant GSK3 beta inhibitors, tideglusib and valproate, exhibited significantly decreased alveolar protein concentrations, which was associated with improved lung function and histopathology. Together, we discovered that the TGF-beta-GSK3 beta-megalin axis is centrally involved in disturbances of alveolar protein clearance in acute lung injury and provide preclinical evidence for therapeutic efficacy of GSK3 beta inhibition.



Citation Styles

Harvard Citation styleVohwinkel, C., Buchaeckert, Y., Al-Tamari, H., Mazzocchi, L., Eltzschig, H., Mayer, K., et al. (2017) Restoration of Megalin-Mediated Clearance of Alveolar Protein as a Novel Therapeutic Approach for Acute Lung Injury, American Journal of Respiratory Cell and Molecular Biology, 57(5), pp. 589-602. https://doi.org/10.1165/rcmb.2016-0358OC

APA Citation styleVohwinkel, C., Buchaeckert, Y., Al-Tamari, H., Mazzocchi, L., Eltzschig, H., Mayer, K., Morty, R., Herold, S., Seeger, W., Pullamsetti, S., & Vadasz, I. (2017). Restoration of Megalin-Mediated Clearance of Alveolar Protein as a Novel Therapeutic Approach for Acute Lung Injury. American Journal of Respiratory Cell and Molecular Biology. 57(5), 589-602. https://doi.org/10.1165/rcmb.2016-0358OC



Keywords


acute respiratory distress syndromealveolar epitheliumGLYCOGEN-SYNTHASE KINASE-3GSK-3 INHIBITOR TIDEGLUSIBPROGRESSIVE SUPRANUCLEAR PALSYprotein transportpulmonary edematransforming growth factor betaTRANSFORMING GROWTH-FACTOR-BETA-1TYROSINE PHOSPHORYLATION

Last updated on 2025-10-06 at 10:48